Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Fernanda Scantamburlo Fernandes"'
Autor:
Mikkel Zöllner Ankarfeldt, Janne Petersen, Jon Trærup Andersen, Maria Fernanda Scantamburlo Fernandes, Hu Li, Stephen Paul Motsko, Thomas Fast, Espen Jimenez-Solem
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 1, Pp 69-81 (2022)
Abstract Background Depression or depressive symptoms are common among pregnant women. The use of antidepressants during pregnancy has grown steadily. The risk of offspring being born small for gestational age or prematurely when exposed to duloxetin
Externí odkaz:
https://doaj.org/article/eec97795a3db4383ada4568ad49cb505
Autor:
Amalia Alexe, Osa Eisele, Maria Fernanda Scantamburlo Fernandes, David Lewis, Nadezda Abramova, Leesha Balramsingh-Harry, Anju Garg, Birgit Kovacs, Keele Wurst, Yenlik Zheteyeva
Globally, more than 200 million women become pregnant each year, most of whom receive medications despite limited information on their safe use during pregnancy. The paucity of drug safety data on pregnant and breastfeeding women stems from the routi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2496aff2061cc90a1bd41e8dcf02b146
https://doi.org/10.22541/au.167061286.68506279/v1
https://doi.org/10.22541/au.167061286.68506279/v1
Autor:
Brian T. Bateman, Hu Li, Sonia Hernandez-Diaz, Helen Mogun, Raisa Levin, Lily G. Bessette, Himanshu P. Upadhyaya, Ajinkya Pawar, Krista F. Huybrechts, Maria Fernanda Scantamburlo Fernandes, Stephen P. Motsko
Publikováno v:
The BMJ
Objective To evaluate the risk of adverse maternal and infant outcomes following in utero exposure to duloxetine. Design Cohort study nested in the Medicaid Analytic eXtract for 2004-13. Setting Publicly insured pregnancies in the United States. Part